Latest Implantica News & Updates

See the latest news and media coverage for Implantica. We track all announcements, press releases, and industry mentions in real time, all in one place.

Implantica

Developer of implantable medical devices and eHealth platforms

implantica.com

Headquarters: Zug, Switzerland
Founded year: 2003
Company type: Public company
Number of employees: 59–200
Industry: Medical Equipment, Supplies & Distribution

Last updated October 28

Latest news about Implantica

In short: Implantica received FDA approval for RefluxStop and prepared U.S. launch with surgeon training.

Company announcements

October 28 Implantica

Implantica highlights RefluxStop FDA approval

The device has strong European data from 1,800 patients and 38 publications across nine countries.

October 12 Implantica

Implantica launches RefluxStop in the US

FDA approval allows expansion of GERD treatment options for millions. The company thanks Nyelux for analysis.

September 23 Implantica

Implantica announces US approval for RefluxStop

The device aims to restore anti-reflux barrier function. Over 1,800 patients treated in Europe backed by extensive clinical research.

September 10 Implantica

Implantica announces RefluxStop FDA approval

The company invites attendees to a session at the American Foregut Society Meeting discussing mechanisms, data, and global experience.

Media coverage

October 26 Dagens PS

Peter Forsell

Medical technology company Implantica is receiving an injection of SEK 1.2 billion from the company's CEO and major shareholder Peter Forsell. At the same time, he wants a split in compensation...

September 28 Zone Bourse

Implantica AG launches RefluxStop® on the US market at the 2026 meeting of the American Foregut Society

Implantica AG announced that RefluxStop® received an enthusiastic welcome from surgeons and gastroenterologists at the 2026 annual meeting...

September 11 Citeline

FDA Approval In Hand, Implantica Prepares To Launch Mechanical GERD Fix In US

Implantica is launching RefluxStop in the US after a PMA approval that was based entirely on European trial data. A Medicare pass-through decision is expected...

August 20 Yahoo Finance

Implantica's anti-reflux device secures FDA approval to tee up J&J rivalry

Implantica's RefluxStop device for GORD treatment secured a European CE mark in 2018, with almost 1,800 patients treated to date.

Never miss news about Implantica

Track Implantica and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Implantica competitors & trending companies

Browse news for competitors to Implantica and other trending companies.